// App-Quantinova.ai

: The molecular hallmarks and clinical consequences of tumor hypoxia in prostate cancer.

Researchers

Presenter

  • Bhandari Vinayak

Principal Investigators

  • Lydia Liu

  • Shadrielle Espirritu

  • Emilie Lalonde

  • Takafumi Yamaguchi

  • Lawrence Heisler

  • Julie Livingstone

  • Vincent Huang

  • Yu-Jia Shiah

  • Veronica Sabelnykova

  • Fouad Yousif

  • Michael Fraser

  • Melvin Chua

  • Theodorus Van Der Kwast

  • Stanley K. Liu

  • Paul Christopher Boutros

  • Robert G. Bristow

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • National Cancer Centre Singapore, Singapore, Singapore

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Manchester Cancer Research Centre, Manchester, United Kingdom

Locations

  • Canada

  • Singapore

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved